✦ LIBER ✦

Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection

✍ Scribed by Yasuhito Tanaka; Anthony E.T. Yeo; Etsuro Orito; Kiyoaki Ito; Noboru Hirashima; Tatsuya Ide; Michio Sata; Masashi Mizokami

Book ID: 106179499
Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 406 KB
Volume: 39
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-003-1387-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Events occurring at the time of breakthr

Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B

✍ Osamu Yokosuka 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 89 KB

Lamivudine monotherapy for spontaneous s

Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B

✍ AKIHITO TSUBOTA; YASUJI ARASE; YOSHIYUKI SUZUKI; FUMITAKA SUZUKI; HITOMI SEZAKI; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Interferon for treatment of breakthrough

Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy

✍ Fumitaka Suzuki; Akihito Tsubota; Norio Akuta; Takashi Someya; Masahiro Kobayash 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 265 KB

Dynamics of lamivudine-resistant hepatit

Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy

✍ Samreen Ijaz; Catherine Arnold; Samir Dervisevic; Jana Mechurova; Nick Tatman; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Adefovir dipivoxil has been used alone or together with lamivudine to suppress lamivudine‐resistant hepatitis B virus (HBV). However, the dynamics of HBV populations under different selection pressures and their impact on treatment outcome are poorly understood. Pyrosequencing® was appl

Systematic review: lamivudine prophylaxi

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection

✍ H. E. KOHRT; D. L. OUYANG; E. B. KEEFFE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

Lamivudine monotherapy in HBeAg-negative

Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome

✍ S. MANOLAKOPOULOS; S. BETHANIS; J. ELEFSINIOTIS; S. KARATAPANIS; C. TRIANTOS; G. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB